Two Halifax startups – both of which work in the intersection of IT and life sciences – have announced a collaboration to help athletes and coaches make better decisions.

Kinduct Technologies, a data and analytics software provider, and Athletigen Technologies Inc., which analyzes athletes’ DNA, have announced that Kinduct’s software platform will soon incorporate Athletigen’s genetic insights.

Athletigen’s platform analyzes an athlete’s DNA so coaches and athletes can better understand peak performance in training and competition. The Kinduct platform allows organizations to analyze athlete data collected from different sources and then use those insights to make better decisions and improve performance.

Kinduct, whose platform is used by some of the world’s best known sports teams, draws data from a range of sources, and will soon add Athletigen to the platform.

“The partnership with Kinduct is an exciting opportunity, with both companies focused on pushing the limits of human performance,” said Athletigen CEO Jeremy Koenig in a statement. “Clients will now have access to genetic markers combined with performance data, biometric scores and subjective inputs to provide a comprehensive view of the athlete to help understand and improve their in-game performance.”

Affinio To Launch LinkedIn Product

Kinduct’s platform, used by teams in the NHL, MLB, NFL, NBA, MLS, and NCAA, allows for a two-way information exchange between coaches and athletes. its Athlete Management System gives teams the ability to collect, analyze, and act on a wide range of player performance data and content such as training results, sleep schedules, maximum acceleration, deceleration, and heart rate. All of the information captured or calculated within the Kinduct platform supports informed decisions on personalized training and injury recovery programs for every athlete. This new partnership with Athletigen adds genetics as an important new layer of data.

“Athletigen analyzes genetic markers that help athletes understand where their performance strengths and weaknesses truly lie,” said Kinduct CEO Travis McDonough. “The partnership with Athletigen and the integration of their genetic insights into Kinduct’s platform will create a powerful tool for assessing an athlete’s condition and defining the optimal training and recovery programs.”

He added: “We see this combination of performance data and genetics as an important step in maximising player performance while reducing injury risk. Our clients can gain access to each athlete’s genetic foundation to better explain the data we capture.”